Ozde is a PhD candidate at University College London’s School of Pharmacy within the EPSRC-SFI CDT in Transformative Pharmaceutical Technologies, Ozde’s research explores stabilising nebulised mRNA-lipid nanoparticles using PEG-lipid alternatives. Her academic journey and industrial experiences have shaped her expertise in advanced drug delivery. She graduated with first-class honours from Aston University, consistently ranking in the top five of her cohort and achieving the highest mark in Neuropharmacology. Her MPharm research focused on developing multi-layered buccal patches with aripiprazole nanosuspension to enhance the solubility of hydrophobic drugs.
During her placement at AstraZeneca, Ozde conducted research project evaluating excipient compatibility and in vitro–in vivo correlation (IVIVC) for oral drug formulations, using the MicroFlux™ system and developing in vitro models to predict oral absorption of challenging compounds, including PROTACs. At GlaxoSmithKline, she completed the second half of her foundation training year in Product Development and Supply, contributing to projects spanning early phase development to commercial production. She gained hands-on experience with advanced manufacturing techniques, regulatory submissions, and led a process capability project involving single-punch presses and dry granulation simulation.